Select-Gca: Upadacitinib In Giant Cell Arteritis

SELECT-GCA: Upadacitinib in Giant Cell Arteritis

SELECTing the right patients: upadacitinib in GCA

SELECT-GCA: Efficacy and Safety of Upadacitinib

Phase 3 Upadacitinib Trial Shows Promising Results for Giant Cell Arteritis Treatment

Giant Cell Arteritis: Current treatments and future directions.

vasculitisfoundation

Author Interview: Professor Daniel Blockmans, 2024

The Immune-Mediated Inflammatory Disease Forum

5 Signs of Giant Cell Arteritis That You Should Know About

Dr. Diana Girnita - Rheumatologist OnCall

GCA: Normal dose of prednisone? - Giant Cell Arteritis Treatment

Dr. Megan - Prednisone Pharmacist

Rheumatology Patient Education: Giant Cell Arteritis (GCA)

MassGeneralHospital

Understanding Giant Cell Arteritis (GCA): Causes, Symptoms, and Treatment

North American Neuro-Ophthalmology Society

A Challenging Case of Extracranial Giant Cell Arteritis (GCA)

Cleveland Clinic

Living with Giant Cell Arteritis (GCA)

Giant Cell Arteritis - Signs You Should Not Ignore

Dr. Diana Girnita - Rheumatologist OnCall

Actemra is a great option for GCA or Temporal Arteritis

Lonestar Rheumatology

Giant Cell Arteritis (and PMR) Q&A

vasculitisfoundation

Advances in the treatment of giant-cell arteritis (ERN-RITA Webinar)

Giant Cell Arteritis (GCA) Immunohistopathologic Study | Protocol Preview

JoVE (Journal of Visualized Experiments)

Criteria for diagnosis of giant cell arteritis

MedLecturesMadeEasy

Giant cell arteritis: The perspective of a specialised clinician

Giant cell arteritis: The perspective of a patient